Selected research
Industry Research
Cancer Spit Test Device Industry Research Report 2026
Market perspective
The global Cancer Spit Test Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cancer Spit Test Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cancer Spit Test Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cancer Spit Test Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cancer Spit Test Device include Thermo Fisher Scientific, Siemens Healthineers, Sarstedt, Salimetrics, Roche Holding AG, Qiagen, PeriRx, Oasis Diagnostics Corporation and Miraclean Technology Co.,Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cancer Spit Test Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cancer Spit Test Device Market by Company
Thermo Fisher Scientific
Siemens Healthineers
Sarstedt
Salimetrics
Roche Holding AG
Qiagen
PeriRx
Oasis Diagnostics Corporation
Miraclean Technology Co.,Ltd.
Illumina
DNA Genotek Inc.
Color Health Inc
Canvax
BioMerieux
Biocartis Group
BD
Agilent Technologies
Abbott Laboratories
Cancer Spit Test Device Segment by Type
Passive Drool Collection Methods
Oral Swab Collection Methods
Cancer Spit Test Device Segment by Application
Cancer Research Institutes
Hospitals
Diagnostic Laboratories
Oncology Speciality Clinics
Others
Cancer Spit Test Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Spit Test Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cancer Spit Test Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Spit Test Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cancer Spit Test Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cancer Spit Test Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cancer Spit Test Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Passive Drool Collection Methods
- Oral Swab Collection Methods
Applications
- Cancer Research Institutes
- Hospitals
- Diagnostic Laboratories
- Oncology Speciality Clinics
- Others
Companies covered
- Thermo Fisher Scientific
- Siemens Healthineers
- Sarstedt
- Salimetrics
- Roche Holding AG
- Qiagen
- PeriRx
- Oasis Diagnostics Corporation
- Miraclean Technology Co.,Ltd.
- Illumina
- DNA Genotek Inc.
- Color Health Inc
- Canvax
- BioMerieux
- Biocartis Group
- BD
- Agilent Technologies
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cancer Spit Test Device Market Size (2021-2032)
- 2.2.2 Global Cancer Spit Test Device Sales (2021-2032)
- 2.2.3 Global Cancer Spit Test Device Market Average Price (2021-2032)
- 2.3 Cancer Spit Test Device by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Passive Drool Collection Methods
- 2.3.3 Oral Swab Collection Methods
- 2.4 Cancer Spit Test Device by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cancer Research Institutes
- 2.4.3 Hospitals
- 2.4.4 Diagnostic Laboratories
- 2.4.5 Oncology Speciality Clinics
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cancer Spit Test Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cancer Spit Test Device Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Cancer Spit Test Device Revenue of Manufacturers (2021-2026)
- 3.4 Global Cancer Spit Test Device Average Price by Manufacturers (2021-2026)
- 3.5 Global Cancer Spit Test Device Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cancer Spit Test Device, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cancer Spit Test Device, Product Type & Application
- 3.8 Global Manufacturers of Cancer Spit Test Device, Established Date
- 3.9 Global Cancer Spit Test Device Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Cancer Spit Test Device Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 Siemens Healthineers
- 4.2.1 Siemens Healthineers Company Information
- 4.2.2 Siemens Healthineers Business Overview
- 4.2.3 Siemens Healthineers Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Siemens Healthineers Cancer Spit Test Device Product Portfolio
- 4.2.5 Siemens Healthineers Recent Developments
- 4.3 Sarstedt
- 4.3.1 Sarstedt Company Information
- 4.3.2 Sarstedt Business Overview
- 4.3.3 Sarstedt Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sarstedt Cancer Spit Test Device Product Portfolio
- 4.3.5 Sarstedt Recent Developments
- 4.4 Salimetrics
- 4.4.1 Salimetrics Company Information
- 4.4.2 Salimetrics Business Overview
- 4.4.3 Salimetrics Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Salimetrics Cancer Spit Test Device Product Portfolio
- 4.4.5 Salimetrics Recent Developments
- 4.5 Roche Holding AG
- 4.5.1 Roche Holding AG Company Information
- 4.5.2 Roche Holding AG Business Overview
- 4.5.3 Roche Holding AG Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Roche Holding AG Cancer Spit Test Device Product Portfolio
- 4.5.5 Roche Holding AG Recent Developments
- 4.6 Qiagen
- 4.6.1 Qiagen Company Information
- 4.6.2 Qiagen Business Overview
- 4.6.3 Qiagen Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Qiagen Cancer Spit Test Device Product Portfolio
- 4.6.5 Qiagen Recent Developments
- 4.7 PeriRx
- 4.7.1 PeriRx Company Information
- 4.7.2 PeriRx Business Overview
- 4.7.3 PeriRx Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 PeriRx Cancer Spit Test Device Product Portfolio
- 4.7.5 PeriRx Recent Developments
- 4.8 Oasis Diagnostics Corporation
- 4.8.1 Oasis Diagnostics Corporation Company Information
- 4.8.2 Oasis Diagnostics Corporation Business Overview
- 4.8.3 Oasis Diagnostics Corporation Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Oasis Diagnostics Corporation Cancer Spit Test Device Product Portfolio
- 4.8.5 Oasis Diagnostics Corporation Recent Developments
- 4.9 Miraclean Technology Co.,Ltd.
- 4.9.1 Miraclean Technology Co.,Ltd. Company Information
- 4.9.2 Miraclean Technology Co.,Ltd. Business Overview
- 4.9.3 Miraclean Technology Co.,Ltd. Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Miraclean Technology Co.,Ltd. Cancer Spit Test Device Product Portfolio
- 4.9.5 Miraclean Technology Co.,Ltd. Recent Developments
- 4.10 Illumina
- 4.10.1 Illumina Company Information
- 4.10.2 Illumina Business Overview
- 4.10.3 Illumina Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Illumina Cancer Spit Test Device Product Portfolio
- 4.10.5 Illumina Recent Developments
- 4.11 DNA Genotek Inc.
- 4.11.1 DNA Genotek Inc. Company Information
- 4.11.2 DNA Genotek Inc. Business Overview
- 4.11.3 DNA Genotek Inc. Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 DNA Genotek Inc. Cancer Spit Test Device Product Portfolio
- 4.11.5 DNA Genotek Inc. Recent Developments
- 4.12 Color Health Inc
- 4.12.1 Color Health Inc Company Information
- 4.12.2 Color Health Inc Business Overview
- 4.12.3 Color Health Inc Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Color Health Inc Cancer Spit Test Device Product Portfolio
- 4.12.5 Color Health Inc Recent Developments
- 4.13 Canvax
- 4.13.1 Canvax Company Information
- 4.13.2 Canvax Business Overview
- 4.13.3 Canvax Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Canvax Cancer Spit Test Device Product Portfolio
- 4.13.5 Canvax Recent Developments
- 4.14 BioMerieux
- 4.14.1 BioMerieux Company Information
- 4.14.2 BioMerieux Business Overview
- 4.14.3 BioMerieux Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 BioMerieux Cancer Spit Test Device Product Portfolio
- 4.14.5 BioMerieux Recent Developments
- 4.15 Biocartis Group
- 4.15.1 Biocartis Group Company Information
- 4.15.2 Biocartis Group Business Overview
- 4.15.3 Biocartis Group Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Biocartis Group Cancer Spit Test Device Product Portfolio
- 4.15.5 Biocartis Group Recent Developments
- 4.16 BD
- 4.16.1 BD Company Information
- 4.16.2 BD Business Overview
- 4.16.3 BD Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 BD Cancer Spit Test Device Product Portfolio
- 4.16.5 BD Recent Developments
- 4.17 Agilent Technologies
- 4.17.1 Agilent Technologies Company Information
- 4.17.2 Agilent Technologies Business Overview
- 4.17.3 Agilent Technologies Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Agilent Technologies Cancer Spit Test Device Product Portfolio
- 4.17.5 Agilent Technologies Recent Developments
- 4.18 Abbott Laboratories
- 4.18.1 Abbott Laboratories Company Information
- 4.18.2 Abbott Laboratories Business Overview
- 4.18.3 Abbott Laboratories Cancer Spit Test Device Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Abbott Laboratories Cancer Spit Test Device Product Portfolio
- 4.18.5 Abbott Laboratories Recent Developments
5 Global Cancer Spit Test Device Market Scenario by Region
- 5.1 Global Cancer Spit Test Device Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cancer Spit Test Device Sales by Region: 2021-2032
- 5.2.1 Global Cancer Spit Test Device Sales by Region: 2021-2026
- 5.2.2 Global Cancer Spit Test Device Sales by Region: 2027-2032
- 5.3 Global Cancer Spit Test Device Revenue by Region: 2021-2032
- 5.3.1 Global Cancer Spit Test Device Revenue by Region: 2021-2026
- 5.3.2 Global Cancer Spit Test Device Revenue by Region: 2027-2032
- 5.4 North America Cancer Spit Test Device Market Facts & Figures by Country
- 5.4.1 North America Cancer Spit Test Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cancer Spit Test Device Sales by Country (2021-2032)
- 5.4.3 North America Cancer Spit Test Device Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cancer Spit Test Device Market Facts & Figures by Country
- 5.5.1 Europe Cancer Spit Test Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cancer Spit Test Device Sales by Country (2021-2032)
- 5.5.3 Europe Cancer Spit Test Device Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cancer Spit Test Device Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cancer Spit Test Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cancer Spit Test Device Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cancer Spit Test Device Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cancer Spit Test Device Market Facts & Figures by Country
- 5.7.1 South America Cancer Spit Test Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cancer Spit Test Device Sales by Country (2021-2032)
- 5.7.3 South America Cancer Spit Test Device Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cancer Spit Test Device Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cancer Spit Test Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cancer Spit Test Device Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cancer Spit Test Device Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cancer Spit Test Device Sales by Type (2021-2032)
- 6.1.1 Global Cancer Spit Test Device Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Cancer Spit Test Device Sales Market Share by Type (2021-2032)
- 6.2 Global Cancer Spit Test Device Revenue by Type (2021-2032)
- 6.2.1 Global Cancer Spit Test Device Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cancer Spit Test Device Revenue Market Share by Type (2021-2032)
- 6.3 Global Cancer Spit Test Device Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cancer Spit Test Device Sales by Application (2021-2032)
- 7.1.1 Global Cancer Spit Test Device Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Cancer Spit Test Device Sales Market Share by Application (2021-2032)
- 7.2 Global Cancer Spit Test Device Revenue by Application (2021-2032)
- 7.2.1 Global Cancer Spit Test Device Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cancer Spit Test Device Revenue Market Share by Application (2021-2032)
- 7.3 Global Cancer Spit Test Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cancer Spit Test Device Value Chain Analysis
- 8.1.1 Cancer Spit Test Device Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cancer Spit Test Device Production Mode & Process
- 8.2 Cancer Spit Test Device Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cancer Spit Test Device Distributors
- 8.2.3 Cancer Spit Test Device Customers
9 Global Cancer Spit Test Device Analyzing Market Dynamics
- 9.1 Cancer Spit Test Device Industry Trends
- 9.2 Cancer Spit Test Device Industry Drivers
- 9.3 Cancer Spit Test Device Industry Opportunities and Challenges
- 9.4 Cancer Spit Test Device Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst